Mesoblast Ltd Announces New Share Issuance
Ticker: MEOBF · Form: 6-K · Filed: Dec 23, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Dec 23, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: new-issue, director-dealings, filing
TL;DR
MESO dropping news: new shares issued, director interests updated. Check the ASX.
AI Summary
On December 20, 2024, Mesoblast Limited announced a new share issuance and filed change of directors' interest notices (Appendix 3Y) with the Australian Securities Exchange. The company is incorporated in Australia and its CEO is Silviu Itescu.
Why It Matters
This filing indicates potential capital raising activities or changes in director holdings, which could impact the company's financial structure and insider ownership.
Risk Assessment
Risk Level: medium — New share issuances can dilute existing shareholders, and changes in director interests may signal strategic shifts or personal financial decisions.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- December 20, 2024 (date) — Announcement date
- Australian Securities Exchange (company) — Filing location
FAQ
What is the purpose of the new issue announcement filed by Mesoblast Limited?
The filing states that Mesoblast Limited filed a new issue announcement with the Australian Securities Exchange on December 20, 2024.
What are Appendix 3Y notices?
Appendix 3Y notices are change of directors' interest notices, which Mesoblast Limited filed along with the new issue announcement.
Who is the CEO of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Where is Mesoblast Limited incorporated?
Mesoblast Limited is incorporated in Australia.
What is the filing date of this Form 6-K?
This Form 6-K was filed on December 23, 2024.
Filing Stats: 268 words · 1 min read · ~1 pages · Grade level 15.6 · Accepted 2024-12-23 06:16:49
Filing Documents
- a2024-12x23appendix3y2a.htm (6-K) — 22KB
- exhibit991.htm (EX-99.1) — 5KB
- exhibit992.htm (EX-99.2) — 6KB
- exhibit991001.jpg (GRAPHIC) — 131KB
- exhibit991002.jpg (GRAPHIC) — 126KB
- exhibit991003.jpg (GRAPHIC) — 39KB
- exhibit992001.jpg (GRAPHIC) — 75KB
- exhibit992002.jpg (GRAPHIC) — 61KB
- exhibit992003.jpg (GRAPHIC) — 69KB
- exhibit992004.jpg (GRAPHIC) — 80KB
- exhibit992005.jpg (GRAPHIC) — 72KB
- exhibit992006.jpg (GRAPHIC) — 98KB
- 0001345099-24-000089.txt ( ) — 1069KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated December 23, 2024 INDEX TO EXHIBITS Item 99.1 Appendix 3Y of Mesoblast Ltd, dated December 20, 2024 . 99.2 Appendix 2A of Mesoblast Ltd, dated December 20, 2024 .